TASK DEFINITION: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
PROBLEM: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Antimicrobial Data Collection Act''.

SEC. 2. RESEARCH PROGRAMS TO STUDY ANTIMICROBIAL RESISTANCE.

    (a) Definitions.--In this Act--
            (1) the term ``Commissioner'' means the Commissioner of 
        Food and Drugs; and
            (2) the term ``Secretary'' means the Secretary of Health 
        and Human Services.
    (b) Commencement of Pilot Data Collection and Analysis Program.--
The Secretary, acting through the Commissioner, shall develop a 
research program or programs to study the relationship between the 
sales, distribution, end-use practices of animal drugs containing an 
antimicrobial active ingredient in food-producing animals and 
antimicrobial resistance trends. The Secretary may also consider any 
other available sound information, science, research, expertise, or 
program designs in carrying out this subsection.
    (c) Purpose of Programs.--Any research program developed under 
subsection (b) shall be developed in order to better determine--
            (1) the relationships between sales data, distribution 
        data, and end-usage data of animal drugs containing an 
        antimicrobial active ingredient in food-producing animals to 
        inform policies of Food and Drug Administration regarding data 
        collection and regulation of antimicrobial products in 
        agriculture, including consideration of the potential value and 
        feasibility of data from veterinary feed directives and other 
        sources; and
            (2) the relationships between the use of animal drugs 
        containing an antimicrobial active ingredient in food-producing 
        animals and trends in antimicrobial resistance, including by 
        using the data collected through the National Antimicrobial 
        Resistance Monitoring System or other studies regarding 
        resistance levels in bacteria associated with food-producing 
        animals.
    (d) Consultation.--Any research program developed under subsection 
(b) shall be developed in consultation with the Secretary of 
Agriculture, which shall include at a minimum consultation with the 
Under Secretary for Food Safety, the Under Secretary for Marketing and 
Regulatory Programs, and the Under Secretary for Research, Education, 
and Economics at the Department of Agriculture. To the extent 
practicable, such Under Secretaries shall provide assistance in 
developing and conducting such research programs.
    (e) Implementation.--Not later than 180 days after the date of 
enactment of this Act, the Secretary shall implement the research 
program or programs developed under subsection (b). The Secretary shall 
analyze data from such program or programs to determine the 
contribution of such data to studying antimicrobial resistance and 
establishing the antimicrobial data collection strategy as described in 
section 3(b)(1)(B).

SEC. 3. REPORTS TO CONGRESS; DEVELOPMENT OF DATA COLLECTION STRATEGY.

    (a) Initial Report.--As soon as practicable after the date of 
enactment of this Act, the Secretary shall--
            (1) submit to Congress a report that--
                    (A) describes the research design and goals for the 
                research program or programs developed under section 
                2(b); and
                    (B) includes a needs assessment, considering broad 
                sources of data and models on antimicrobial use in 
                food-producing animals that the Food and Drug 
                Administration may need or from which the Food and Drug 
                Administration could benefit, to improve the evaluation 
                of Food and Drug Administration programs regarding 
                antimicrobial resistance and how a systematic and valid 
                data collection strategy will be designed to comply 
                with subsection (b)(1)(B); and
            (2) make such report publicly available.
    (b) Report Regarding Results and Recommendations.--Not later than 2 
years after the date of enactment of this Act, the Secretary shall--
            (1) submit to Congress a report that--
                    (A) describes the comprehensive results of any 
                research program or programs developed under section 
                2(b), including with respect to the determinations made 
                pursuant to paragraphs (1) and (2) of section 2(c); and
                    (B) provides recommendations for developing an 
                antimicrobial data collection strategy based on the 
                information contained in the comments to the Advanced 
                Notice of Proposed Rulemaking entitled ``Antimicrobial 
                Animal Drug Distribution Reporting'' (77 Fed. Reg. 
                44177 (July 27, 2012)) and any relevant information 
                obtained in the research pilot program carried out 
                under section 2; and
            (2) make such report publicly available.

SEC. 4. ENHANCED REPORTING AND PUBLICATION OF SALES DATA.

    (a) In General.--Section 512(l)(3)(E) of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 360b(l)(3)(E)) is amended--
            (1) by redesignating clauses (i) and (ii) as subclauses (I) 
        and (II);
            (2) by striking ``The Secretary shall make summaries of the 
        information reported under this paragraph publicly available, 
        except that--'' and inserting ``(i) Not later than a date 
        established by the Secretary for 2014, and on such date in each 
        year thereafter, the Secretary shall make publicly available a 
        summary of the information (including dosage form information, 
        if practicable) reported under this paragraph for the previous 
        year, except that--''; and
            (3) by inserting after subclause (II), as redesignated by 
        paragraph (1), the following:
    ``(ii) In making the summaries available under this subparagraph, 
the following shall apply:
            ``(I) The Secretary shall segregate the categories of 
        amounts reported into the following 2 subcategories, after 
        consultation with applicable classifications as determined by 
        the Secretary, subject to subclause (IV):
                    ``(aa) The volume of drugs of importance to human 
                medicine.
                    ``(bb) The volume of drugs not of importance to 
                human medicine.
            ``(II) As practicable, the Secretary shall segregate 
        amounts reported into the following:
                    ``(aa) Container size.
                    ``(bb) Strength.
                    ``(cc) Dosage form.
                    ``(dd) Marketing status.
            ``(III) In any cross-tabulation of the amounts reported 
        with any reporting category, the Secretary shall include the 
        categories `Not Independently Reported' and `Not Independently 
        Reported Export'.
            ``(IV) Every 5 years, the Secretary shall reevaluate the 
        classifications consulted under subclause (I) after opportunity 
        for public comment.
    ``(iii) The Secretary shall maximize the quality, accuracy, detail, 
and specificity of data made publicly available in the summaries under 
this subparagraph, to the extent practicable, such as regarding the 
type, estimated level of exposure, and target animals of antimicrobial 
drugs. In carrying out the preceding sentence, the Secretary may 
provide additional information in such summaries.
    ``(iv) The Secretary shall conduct an annual evaluation of the 
effectiveness of and compliance with relevant policies and programs of 
the Food and Drug Administration regarding antimicrobial drug sales for 
food-producing animals, and use of such drugs and antimicrobial 
resistance, using valid and robust performance metrics. Beginning in 
2014, the Secretary shall include with each annual summary made 
publicly available under this subparagraph a report that describes the 
results of the evaluation conducted under this clause with respect to 
the preceding year.''.
    (b) Reissuance.--Not later than 3 years after the date of enactment 
of this Act, the Secretary shall reissue the summary reports issued 
before 2012 under section 512(l)(3)(E) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 360b(l)(3)(E)) using the format designed for 
the 2012 summary report. The Secretary shall publish the reissued 
reports in one combined publication.

SEC. 5. ACTION TO PROTECT PUBLIC AND ANIMAL HEALTH.

    (a) Publication of Final Guidance.--
            (1) In general.--Not later than 180 days after the date of 
        enactment of this Act, the Secretary shall publish a final 
        version of the draft Voluntary Guidance #213 of the Food and 
        Drug Administration (entitled ``New Animal Drugs and New Animal 
        Drug Combination Products Administered in or on Medicated Feed 
        or Drinking Water of Food-Producing Animals: Recommendations 
        for Drug Sponsors for Voluntarily Aligning Product Use 
        Conditions with GFI #209'').
            (2) Effect of subsection.--Nothing in this subsection shall 
        be construed to affect any other obligations of the Food and 
        Drug Administration regarding the authorities of such 
        Administration to regulate antimicrobial drugs and protect 
        public health.
    (b) Report by GAO.--
            (1) In general.--Not later than 3 years after the 
        conclusion of the research pilot program or programs developed 
        under section 2, the Comptroller General of the United States 
        shall commence a study to evaluate--
                    (A) the approaches used by the Food and Drug 
                Administration to eliminate injudicious use of 
                antimicrobial drugs in food-producing animals; and
                    (B) the effectiveness of the data collection 
                activities carried out by the Food and Drug 
                Administration regarding antimicrobial resistance.
            (2) Report.--Not later than 1 year after commencing the 
        study described in paragraph (1), the Comptroller General of 
        the United States shall submit to the Committee on Health, 
        Education, Labor, and Pensions of the Senate and the Committee 
        on Energy and Commerce of the House of Representatives a report 
        that describes the results of such study.

SOLUTION: Antimicrobial Data Collection Act - Requires the Secretary of Health and Human Services (HHS), acting through the Commissioner of Food and Drugs (FDA), to develop a research program to study the relationship between the sales, distribution, and end-use practices of animal drugs containing an antimicrobial active ingredient in food-producing animals and antimicrobial resistance trends. Requires the Secretary to analyze data from the program to determine the data's contribution to studying antimicrobial resistance and establishing an antimicrobial data collection strategy. Requires the Secretary to: (1) report to Congress on the program's research design and goals, including a needs assessment to improve the FDA's evaluation of antimicrobial resistance; and (2) report to Congress and the public within two years with the comprehensive results of the program and recommendations for developing an antimicrobial data collection strategy. Amends the Federal Food, Drug, and Cosmetic Act to revise the requirements for the annual summaries of antimicrobial animal drug information, including by requiring the Secretary to maximize the quality, accuracy, detail, and specificity of the data made publicly available in the summaries. Requires the Secretary to conduct an annual evaluation of the effectiveness of and compliance with relevant FDA programs and policies regarding antimicrobial drug sales for food-producing animals, and the use of such drugs and antimicrobial resistance. Directs the Secretary to publish a final version of voluntary guidance for drug sponsors on new animal drugs and new animal drug combination products administered in or on medicated feed or drinking water of food-producing animals. Requires the Comptroller General (GAO) to evaluate the FDA's approaches to eliminate injudicious use of antimicrobial drugs in food-producing animals and the effectiveness of the FDA's data collection activities regarding antimicrobial resistance.

PROBLEM: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Children's Firearm Marketing Safety 
Act''.

SEC. 2. PROHIBITION OF MARKETING FIREARMS TO CHILDREN.

    (a) Conduct Prohibited.--Not later than one year after the date of 
the enactment of this Act, the Federal Trade Commission shall 
promulgate rules in accordance with section 553 of title 5, United 
States Code, to prohibit any person from marketing firearms to 
children. Such rules shall include the following:
            (1) A prohibition on the use of cartoon characters to 
        promote firearms and firearm products.
            (2) A prohibition on firearm brand name merchandise 
        marketed for children (such as hats, t-shirts, and stuffed 
        animals).
            (3) A prohibition on the use of firearm marketing campaigns 
        with the specific intent to appeal to children.
            (4) A prohibition on the manufacturing of a gun with colors 
        or designs that are specifically designed with the purpose to 
        appeal to children.
            (5) A prohibition on the manufacturing of a gun intended 
        for use by children that does not clearly and conspicuously 
        note the risk posed by the firearm by labeling somewhere 
        visible on the firearm any of the following:
                    (A) ``Real gun, not a toy.''.
                    (B) ``Actual firearm the use of which may result in 
                death or serious bodily injury.''.
                    (C) ``Dangerous weapon''.
                    (D) Other similar language determined by the 
                Federal Trade Commission.
    (b) Enforcement.--
            (1) Unfair or deceptive acts or practices.--A violation of 
        a rule promulgated under subsection (a) shall be treated as a 
        violation of a regulation under section 18(a)(1)(B) of the 
        Federal Trade Commission Act (15 U.S.C. 57a(a)(1)(B)) regarding 
        unfair or deceptive acts or practices.
            (2) Powers of commission.--The Federal Trade Commission 
        shall enforce this Act in the same manner, by the same means, 
        and with the same jurisdiction as though all applicable terms 
        and provisions of the Federal Trade Commission Act were 
        incorporated into and made a part of this Act. Any person who 
        violates the regulations promulgated under subsection (a) shall 
        be subject to the penalties and entitled to the privileges and 
        immunities provided in the Federal Trade Commission Act.
    (c) Actions by States.--
            (1) In general.--In any case in which the attorney general 
        of a State has reason to believe that an interest of the 
        residents of such State has been or is threatened or adversely 
        affected by an act or practice in violation of a rule 
        promulgated under subsection (a), the State, as parens patriae, 
        may bring a civil action on behalf of the residents of the 
        State in an appropriate State court to--
                    (A) enjoin such act or practice;
                    (B) enforce compliance with such rule;
                    (C) obtain damages, restitution, or other 
                compensation on behalf of residents of the State; or
                    (D) obtain such other legal and equitable relief as 
                the court may consider to be appropriate.
            (2) Notice.--Before filing an action under this subsection, 
        the attorney general, official, or agency of the State involved 
        shall provide to the Federal Trade Commission a written notice 
        of such action and a copy of the complaint for such action. If 
        the attorney general, official, or agency determines that it is 
        not feasible to provide the notice described in this paragraph 
        before the filing of the action, the attorney general, 
        official, or agency shall provide written notice of the action 
        and a copy of the complaint to the Federal Trade Commission 
        immediately upon the filing of the action.
            (3) Authority of federal trade commission.--
                    (A) In general.--On receiving notice under 
                paragraph (2) of an action under this subsection, the 
                Federal Trade Commission shall have the right--
                            (i) to intervene in the action;
                            (ii) upon so intervening, to be heard on 
                        all matters arising therein; and
                            (iii) to file petitions for appeal.
                    (B) Limitation on state action while federal action 
                is pending.--If the Federal Trade Commission or the 
                Attorney General of the United States has instituted a 
                civil action for violation of a rule promulgated under 
                subsection (a) (referred to in this subparagraph as the 
                ``Federal action''), no State attorney general, 
                official, or agency may bring an action under this 
                subsection during the pendency of the Federal action 
                against any defendant named in the complaint in the 
                Federal action for any violation of such rule alleged 
                in such complaint.
            (4) Rule of construction.--For purposes of bringing a civil 
        action under this subsection, nothing in this Act shall be 
        construed to prevent an attorney general, official, or agency 
        of a State from exercising the powers conferred on the attorney 
        general, official, or agency by the laws of such State to 
        conduct investigations, administer oaths and affirmations, or 
        compel the attendance of witnesses or the production of 
        documentary and other evidence.
    (d) Definitions.--In this section:
            (1) Child.--The term ``child'' means an individual that is 
        less than 18 years of age.
            (2) Firearm.--The term ``firearm'' has the meaning given 
        that term in section 921 of title 18, United States Code.

SOLUTION: Children's Firearm Marketing Safety Act - Directs the Federal Trade Commission (FTC) to promulgate rules to prohibit the marketing of firearms to children, including prohibitions against:   the use of cartoon characters to promote firearms and firearm products,  firearm brand name merchandise marketed for children, the use of firearm marketing campaigns with the specific intent to appeal to children, the manufacturing of a gun with colors or designs that are specifically designed to appeal to children, and  the manufacturing of a gun intended for use by children that does not clearly and conspicuously note, by specified warnings on the firearm, the risk posed by the firearm by labeling somewhere visible on the firearm.  Treats violations of such rules as violations of Federal Trade Commission Act regulations regarding unfair or deceptive acts or practices. Provides for enforcement of this Act by the FTC and through civil actions by state attorneys general.

PROBLEM: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Child Product Safety Notification 
Act''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Unintentional injuries are the leading cause of death 
        among children, and for every such injury that is fatal, 
        approximately 18 children are hospitalized and 1,250 are 
        treated by emergency departments for such injuries that are 
        nonfatal.
            (2) According to the Consumer Product Safety Commission, an 
        average of 50 children under the age of 5 die each year in 
        incidents associated with nursery products, and about 16 of 
        these deaths each year are associated with cribs.
            (3) In 2003, an estimated 60,700 children under the age of 
        5 were treated in United States hospital emergency rooms for 
        injuries associated with nursery products, and there were 
        10,700 injuries to children under the age of 5 years associated 
        with strollers alone.
            (4) Of the 397 recalls issued by the Consumer Product 
        Safety Commission in fiscal year 2005, 109 (or 28 percent) were 
        children's products. Children's products were recalled, on 
        average, over 2 times per week, and accounted for 19,635,627 
        individual units.

SEC. 3. DEFINITIONS.

    In this Act:
            (1) Commission.--The term ``Commission'' means the Consumer 
        Product Safety Commission.
            (2) Durable infant or toddler product.--The term ``durable 
        infant or toddler product''--
                    (A) means a durable product intended for use, or 
                that may be reasonably expected to be used, by children 
                under the age of 5 years; and
                    (B) includes--
                            (i) full-size cribs and nonfull-size cribs;
                            (ii) toddler beds;
                            (iii) high chairs, booster chairs, and 
                        hook-on chairs;
                            (iv) bath seats;
                            (v) gates and other enclosures for 
                        confining a child;
                            (vi) play yards;
                            (vii) stationary activity centers;
                            (viii) child carriers;
                            (ix) strollers;
                            (x) walkers;
                            (xi) swings;
                            (xii) bassinets and cradles; and
                            (xiii) children's folding chairs.

SEC. 4. CONSUMER PRODUCT REGISTRATION FORMS.

    (a) Rulemaking.--Not later than 270 days after the date of 
enactment of this Act, the Commission shall, pursuant to its authority 
under section 16(b) of the Consumer Product Safety Act (15 U.S.C. 
2065(b)), promulgate a final consumer product safety standard under 
section 7 of such Act (15 U.S.C. 2056) to require manufacturers of 
durable infant or toddler products--
            (1) to provide consumers with a postage-paid consumer 
        registration form with each such product;
            (2) to maintain a record of the names, addresses, email 
        addresses, and other contact information of consumers who 
        register their ownership of such products with the manufacturer 
        in order to improve the effectiveness of manufacturer campaigns 
        to recall such products; and
            (3) to permanently place the manufacturer name and contact 
        information, model name and number, and the date of manufacture 
        on each durable infant or toddler product.
    (b) Requirements for Registration Form.--The registration form 
required to be provided to consumers under subsection (a) shall--
            (1) include spaces for a consumer to provide their name, 
        address, telephone number, and email address;
            (2) include space sufficiently large to permit easy, 
        legible recording of all desired information;
            (3) be attached to the surface of each durable infant or 
        toddler product so that, as a practical matter, the consumer 
        must notice and handle the form after purchasing the product;
            (4) include the manufacturer's name, model name and number 
        for the product, and the date of manufacture;
            (5) include a message explaining the purpose of the 
        registration and designed to encourage consumers to complete 
        the registration;
            (6) include an option for consumers to register through the 
        Internet; and
            (7) a statement that information provided by the consumer 
        shall not be used for any purpose other than to facilitate a 
        recall of or safety alert regarding that product.
In issuing regulations under this section, the Commission may prescribe 
the exact text and format of the required registration form.
    (c) Record Keeping and Notification Requirements.--The standard 
required under this section shall require each manufacturer of a 
durable infant or toddler product to maintain a record of registrants 
for each product manufactured that includes all of the information 
provided by each consumer registered, and to use such information to 
notify such consumers in the event of a voluntary or involuntary recall 
of or safety alert regarding such product. Each manufacturer shall 
maintain such a record for a period of not less than 6 years after the 
date of manufacture of the product. Consumer information collected by a 
manufacturer under this Act may not be used by the manufacturer, nor 
disseminated by such manufacturer to any other party, for any purpose 
other than notification to such consumer in the event of a product 
recall or safety alert.
    (d) Study.--The Commission shall conduct a study at such time as it 
considers appropriate on the effectiveness of the consumer registration 
forms in facilitating product recalls. Upon the conclusion of such 
study, the Commission shall report its findings to Congress.

SOLUTION:
Child Product Safety Notification Act - Instructs the Consumer Product Safety Commission to promulgate a final consumer product safety standard that requires manufacturers of durable infant or toddler products to: (1) provide consumers with a postage-paid consumer registration form with each such product; (2) maintain a record of registered consumer contact information to improve the effectiveness of product recalls; (3) permanently place the manufacturer name and contact information, model name and number, and the date of manufacture on each durable infant or toddler product; and (4) implement specified recordkeeping and notification requirements.